Stocktoria
BRUKER CORP BRKR
BRUKER CORP (BRKR) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 0.25% (safety: safe). FY2025 revenue was $3.4B at a -0.3% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.56 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-08-05 | Citigroup | Neutral (main) |
| 2026-07-08 | Citigroup | Neutral (main) |
| 2026-07-07 | Leerink Partners | Outperform (main) |
| 2026-06-29 | Guggenheim | Buy (main) |
| 2026-06-24 | Barclays | Overweight (main) |
| 2026-06-08 | JP Morgan | Overweight (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.15 |
| Retained earnings / assets | 0.378 |
| EBIT / assets | 0.011 |
| Equity / liabilities | 0.663 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| BRKR | BRUKER CORP | 4/9 | 2.98 | — | +2.1% |
| WAT | WATERS CORP /DE/ | 4/9 | 10 | 55.1 | +7% |
| RVTY | REVVITY, INC. | 6/9 | 3.86 | 52.3 | +3.7% |
| MTD | METTLER TOLEDO INTERNATIONAL INC/ | 5/9 | — | 29.4 | +4% |
| BIO | BIO-RAD LABORATORIES, INC. | 5/9 | 6.54 | 10.7 | +0.7% |
| ILMN | ILLUMINA, INC. | 7/9 | 3.04 | 31.4 | -0.7% |
| TXG | 10x Genomics, Inc. | 4/9 | 1.63 | — | +5.2% |
About BRUKER CORP
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
FAQ
Is BRKR financially healthy?
BRUKER CORP's Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does BRKR pay a dividend, and is it safe?
Yes. BRUKER CORP pays a dividend yielding about 0.25% with a -265.1% payout ratio, rated “safe” for safety.
How profitable is BRKR?
In FY2025, BRUKER CORP had a net margin of -0.3% and a return on equity of -0.3%.
Is BRKR overvalued or undervalued?
BRUKER CORP trades at about 78.0× trailing earnings — above its 10-year norm (10-year range 24.7×–76.5×, median 37.2×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for BRKR?
The average Wall-Street price target for BRUKER CORP is $58.75, about 0.9% below the recent price, from 12 analysts (consensus: buy).
Is BRKR a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on BRUKER CORP: a Piotroski F-score of 4/9, an Altman Z″ in the safe zone, a dividend yield of 0.25%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.